Efficacy and safety of innovative cosmeceuticals

Clinics in Dermatology

Volumn 26, Issue 4, 2008, Pages 367-374

  Gao, Xing Hua ^a   Zhang, Li ^a   Wei, Huachen ^b   Chen, Hong Duo ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYACID; ADAPALENE; ALPHA2 GLYCOPROTEIN; ARBUTIN; ASCORBATE MAGNESIUM; ASCORBIC ACID; AZELAIC ACID; CHAMOMILE; COSMETIC; DEANOL; FURAN; GLABRIDIN; GLYCOLIC ACID; GREEN TEA EXTRACT; HYDROQUINONE; ISOTRETINOIN; KOJIC ACID; MELANIN; MORINDA CITRIFOLIA EXTRACT; PANTOTHENIC ACID; POMEGRANATE EXTRACT; RETINOIC ACID; RETINOID; SCOPARONE; SKIN WHITENING AGENT; SPHINGOSYLPHOSPHORYLCHOLINE; SUNSCREEN; TAZAROTENE; UBIQUINONE; UNINDEXED DRUG;

ABDOMINAL PAIN; ARTICLE; BLISTER; BURN; BURNING SENSATION; DESQUAMATION; DIZZINESS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; DRUG SYNTHESIS; DRY SKIN; FLATULENCE; HEADACHE; HEARTBURN; HUMAN; MYALGIA; NAUSEA; OCHRONOSIS; PHOTOSENSITIVITY; PRIORITY JOURNAL; PRURITUS; SKIN CARE; SKIN DISCOLORATION; SKIN IRRITATION; SKIN PROTECTION; SKIN REDNESS; SOYBEAN; STOMACH DISCOMFORT; SWELLING;

ANIMALS; COSMETICS; DERMATOLOGIC AGENTS; HUMANS; PLANT EXTRACTS; SKIN AGING; SKIN PIGMENTATION; SUNSCREENING AGENTS;

EID: 48449086174     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2008.01.013     Document Type: Article

References (60)

1. Kligman A. Cosmeceuticals: do we need a new category?. In: Elsner P., and Maiback H. (Eds). Cosmeceuticals (2000), Marcel Dekker, New York 1
2. Dureja H., Kaushik D., Gupta M., et al. Cosmeceutical: an emerging concept. Indian J Pharmacol 37 (2005) 155-159
3. Lee E.S., Kim J.H., Sungbin I.M., et al. Application of computerized image analysis in pigmentary skin diseases. Int J Dermatol 40 (2001) 45-49
4. Yoshimura K., Sato K., Aiba-Kojima E., et al. Repeated treatment protocols for melasma and acquired dermal melanocytosis. Dermatol Surg 32 (2006) 365-371
5. Boissy R.E., Visscher M., and DeLong M.A. DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency. Exp Dermatol 14 (2005) 601-608
6. Chakraborty A.K., Funasaka Y., Komoto M., et al. Effect of arbutin on melanogenic proteins in human melanocytes. Pigment Cell Res 11 (1998) 206-212
7. Maeda K., and Fukuda M. Arbutin: mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther 276 (1996) 765-769
8. Nakamura K., Yoshida M., and Uchiwa H. Down-regulation of melanin synthesis by a biphenyl derivative and its mechanism. Pigment Cell Res 16 (2003) 494-500
9. Usuki A., Ohashi A., Sato H., et al. The inhibitory effect of glycolic acid and lactic acid on melanin synthesis in melanoma cells. Exp Dermatol 12 Suppl 2 (2003) 43-50
10. Galcia A., and Fulton J.E. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg 22 (1996) 443-447
11. Moon K.Y., Ahn K.S., Lee J., et al. Kojic acid, a potential inhibitor of NF-kappaB activation in transfectant human HaCaT and SCC-13 cells. Arch Pharm Res 24 (2001) 307-311
12. Nohynek G.J., Kirkland D., Marzin D., et al. An assessment of the genotoxicity and human health risk of topical use of kojic acid [5-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one]. Food Chem Toxicol 42 (2004) 93-105
13. Wan H.M., Chen C.C., Chang T.S., et al. Combining induced mutation and protoplasting for strain improvement of Aspergillus oryzae for kojic acid production. Biotechnol Lett 26 (2004) 1163-1166
14. Kim D.H., Hwang J.S., Baek H.S., et al. Development of 5-[(3-aminopropyl)phosphinooxy]-2-(hydroxymethyl)-4H-pyran-4-one as a novel whitening agent. Chem Pharm Bull (Tokyo) 51 (2003) 113-116
15. Balina L.M., and Graupe K. The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol 30 (1991) 893-895
16. Draelos Z.D. Cosmeceuticals: procedures in cosmetic dermatology (2005), Elsevier Saunders, Philadelphia 71-79
17. Ortonne J.P. Retinoid therapy of pigmentary disorders. Dermatol Ther 19 (2006) 280-288
18. Gao X.H., Chen H.D., and Kligman A.M. Topical tretinoin for photoaging: the China experience. J Appl Cosmetol 15 (1997) 77-82
19. Yoshimura M., Watanabe Y., Kasai K., et al. Inhibitory effect of an ellagic acid-rich pomegranate extract on tyrosinase activity and ultraviolet-induced pigmentation. Biosci Biotechnol Biochem 69 (2005) 2368-2373
20. Yokota T., Nishio H., and Kubota Y. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res 11 (1998) 355-361
21. Nerya O., Vaya J., Musa R., et al. Glabrene and isoliquiritigenin as tyrosinase inhibitors from licorice roots. J Agric Food Chem 51 (2003) 1201-1207
22. Kim H.J., Seo S.H., Lee B.G., et al. Identification of tyrosinase inhibitors from Glycyrrhiza uralensis. Planta Med 71 (2005) 785-787
23. Kameyama K., Sakai C., Kondoh S., et al. Inhibitory effect of magnesium l-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo. J Am Acad Dermatol 34 (1996) 29-33
24. Curto E.V., Kwong C., Hermersdorfer H., et al. Inhibitors of mammalian melanocyte tyrosinase: in vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors. Biochem Pharmacol 57 (1999) 663-672
25. Kim D.S., Park S.H., Kwon S.B., et al. Sphingosylphosphorylcholine-induced ERK activation inhibits melanin synthesis in human melanocytes. Pigment Cell Res 19 (2006) 146-153
26. Okombi S., Rival D., Bonnet S., et al. Analogues of N-hydroxycinnamoylphenalkylamides as inhibitors of human melanocyte-tyrosinase. Bioorg Med Chem Lett 16 (2006) 2252-2255
27. Kim D.S., Kim S.Y., Chung J.H., et al. Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes. Cell Signal 14 (2002) 779-785
28. Hale L.P. Zinc alpha-2-glycoprotein regulates melanin production by normal and malignant melanocytes. J Invest Dermatol 119 (2002) 464-470
29. Rawlings A.V., and Harding C.R. Moisturization and skin barrier function. Dermatol Ther 175 Suppl 1 (2004) 43-48
30. Baumann L. Cosmetic dermatology: principles and practice (2002), The McGraw-Hill Companies Medical Publishing Division, Boston 29
31. Schzwarts R., and Centurion S.A. Moisturizers. eMedicine (2006) 2
32. Grove G., and Zerweck C. An evaluation of the moisturizing and anti-itch effects of a lactic acid and pramoxine hydrochloride cream. Cutis 73 (2004) 135-139
33. Ebner F., Heller A., Rippke F., et al. Topical use of dexpanthenol in skin disorders. Am J Clin Dermatol 3 (2002) 427-433
34. Chamlin S.L., Kao J., Frieden I.J., et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 47 (2002) 198-208
35. Soma Y., Kashima M., Imaizumi A., et al. Moisturizing effects of topical nicotinamide on atopic dry skin. Int J Dermatol 44 (2005) 197-202
36. Draelos Z.D., Ertel K., and Berge C. Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. Cutis 76 (2005) 135-141
37. El-Kadi K.N., Rawlings A.V., Feinberg C., et al. Broad specificity alkaline proteases efficiently reduce the visual scaling associated with soap-induced xerosis. Arch Dermatol Res 293 (2001) 500-507
38. Glogau R.G. Chemical peeling and aging skin. J Geriatr Dermatol 12 (1994) 31
39. Lee S., Lim J.M., Jin M.H., et al. Partially purified paeoniflorin exerts protective effects on UV-induced DNA damage and reduces facial wrinkles in human skin. J Cosmet Sci 57 (2006) 57-64
40. Kim S.W., Jo B.K., Jeong J.H., et al. Induction of extracellular matrix synthesis in normal human fibroblasts by anthraquinone isolated from Morinda citrifolia (Noni) fruit. J Med Food 8 (2005) 552-555
41. Chi Y.S., Heo M.Y., Chung J.H., et al. Effects of the chestnut inner shell extract on the expression of adhesion molecules, fibronectin and vitronectin, of skin fibroblasts in culture. Arch Pharm Res 25 (2002) 469-474
42. Grossman R. The role of dimethylaminoethanol in cosmetic dermatology. Am J Clin Dermatol 6 (2005) 39-47
43. Hoppe U., Bergemann J., Diembeck W., et al. Coenzyme Q10, a cutaneous antioxidant and energizer. Biofactors 9 (1999) 371-378
44. Kullavanijaya P., and Lim H. Photoprotection. J Am Acad Dermatol 52 (2005) 937-958
45. Wulf H.C., Sandby-Moller J., Kobayasi T., et al. Skin aging and natural photoprotection. Micron 35 (2004) 185-191
46. Varani J., Schuger L., Dame M.K., et al. Reduced fibroblast interaction with intact collagen as a mechanism for depressed collagen synthesis in photodamaged skin. J Invest Dermatol 122 (2004) 1471-1479
47. Naru E., Suzuki T., Moriyama M., et al. Functional changes induced by chronic UVA irradiation to cultured human dermal fibroblasts. Br J Dermatol 153 Suppl 2 (2005) 6-12
48. Sharma S., and Kaur I.P. Development and evaluation of sesamol as an antiaging agent. Int J Dermatol 45 (2006) 200-208
49. Stratigos A.J., and Katsambas A.D. The role of topical retinoids in the treatment of photoaging. Drugs 65 (2005) 1061-1072
50. Baumann L., Vujevich J., Halem M., et al. Open-label pilot study of alitretinoin gel 0.1% in the treatment of photoaging. Cutis 76 (2005) 69-73
51. Wei H., Saladi R., Lu Y., et al. Isoflavone genistein: photoprotection and clinical implications in dermatology. J Nutr 133 Suppl (2003) 3811S-3819S
52. Fitzpatrick R.E., and Rostan E.F. Double-blind, half-face study comparing topical vitamin C and vehicle for rejuvenation of photodamage. Dermatol Surg 28 (2002) 231-236
53. An B.J., Kwak J.H., Son J.H., et al. Physiological activity of irradiated green tea polyphenol on the human skin. Am J Chin Med 33 (2005) 535-546
54. Morlev N., Clifford T., Salter L., et al. The green tea polyphenol (-)-epigallocatechin gallate and green tea can protect human cellular DNA from ultraviolet and visible radiation-induced damage. Photodermatol Photoimmunol Photomed 21 (2005) 15-22
55. Tobi S.E., Gilbert M., Paul N., et al. The green tea polyphenol, epigallocatechin-3-gallate, protects against the oxidative cellular and genotoxic damage of UVA radiation. Int J Cancer 102 (2002) 439-444
56. Chow H.H., Cai Y., Hakim I.A., et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res 15 (2003) 3312-3319
57. Wyszko E., Barciszewska M.Z., Markiewicz M., et al. 'Action-at-a distance' of a new DNA oxidative damage product 6-furfuryl-adenine (kinetin) on template properties of modified DNA. Biochim Biophys Acta 1625 (2003) 239-245
58. Berge U., Kristensen P., and Rattan S.I. Kinetin-induced differentiation of normal human keratinocytes undergoing aging in vitro. Ann N Y Acad Sci 1067 (2006) 332-336
59. Verbeke P., Siboska G.E., Clark B.F., et al. Kinetin inhibits protein oxidation and glycoxidation in vitro. Biochem Biophys Res Commun 276 (2000) 1265-1270
60. Olsen A., Siboska G.E., Clark B.F., et al. N(6)-F-Furfuryladenine, kinetin, protects against Fenton reaction-mediated oxidative damage to DNA. Biochem Biophys Res Commun 265 (1999) 499-502